Dermal fibroblasts (C18)—3uM sphingosine-1-phosphate treated 4hr _vs_ untreated_GPL6480 |
Sphingosine 1-phosphate |
Dermal fibroblasts |
GSE56308 |
4 |
3 |
15.9 |
Dermal fibroblasts (NHDF)—3uM sphingosine-1-phosphate treated 4hr _vs_ untreated_GPL6480 |
Sphingosine 1-phosphate |
Dermal fibroblasts |
GSE56308 |
4 |
3 |
15.7 |
Lung cancer A549 cell line + Nilotinib 30000nM for 4hr _vs_ control |
Nilotinib |
A549 |
E-TABM-585 |
4 |
30 |
15.6 |
Primary mesothelial HPM3 cells, pleural + 5ug/cm2 crocidolite asbestos for 8hr _vs_ unexposed |
Asbestos, crocidolite |
HPM3 |
GSE63966 |
8 |
5ug/cm2 |
15.2 |
Paroxetine_20uM_24hr_Chen |
Paroxetine |
MCF7 |
PMID: 24496634 |
24 |
20 |
13.3 |
Macrophages monocyte-derived 10uM nutlin-3 treated 2hr _vs_ DMSO |
Nutlin 3 |
Monocyte-derived macrophages |
GSE43596 |
2 |
10 |
13.2 |
Dermal fibroblasts (C18)—3uM sphingosine-1-phosphate treated 8hr _vs_ untreated_GPL6480 |
Sphingosine 1-phosphate |
Dermal fibroblasts |
GSE56308 |
8 |
3 |
13.2 |
HUVEC cells + 1.5 mM nickel chloride for 5hr _vs_ control |
Nickel chloride |
HUVEC |
GSE4852 |
5 |
1500 |
12.6 |
Bronchial epithelial BEAS-2B cells treated 4hr with 10ug/ml PM10—indoor _vs_ outdoor |
Particulate matter |
BEAS-2B |
GSE34607 |
4 |
10ug/ml |
12.2 |
Huh7 hepatocarcinoma cells 10uM GENK treated for 4hr _vs_ DMSO control |
Genkwanin |
HuH-7 |
GSE39002 |
4 |
10 |
12.2 |
A549 lung carcinoma cells grown in presence of 10nM geldanamycin (IC20) 48hr _vs_ vehicle |
Geldanamycin |
A549 |
GSE26525 |
48 |
0.01 |
12.2 |
Monocyte derived dendritic cells + TLR4 agonist R848 2hr _vs_ untreated |
R848 |
Monocyte-derived dendridic cells |
GSE2706 |
2 |
2.5 μg/ml |
11.8 |
HEK293 cells overexpression p65-S547A mutant—etoposide treated 8hr _vs_ untreated |
Etoposide |
HEK293 |
GSE33990 |
8 |
Not reported |
11.5 |
Bronchial epithelial BEAS-2B cells—4hr 10ug/ml indoor PM10 _vs_ 4hr untreated |
Particulate matter |
BEAS-2B |
GSE34607 |
4 |
10ug/ml |
11.4 |
Dermal fibroblasts (NHDF)—3uM sphingosine-1-phosphate treated 8hr _vs_ untreated_GPL6480 |
Sphingosine 1-phosphate |
Dermal fibroblasts |
GSE56308 |
8 |
3 |
11.3 |
Dermal fibroblasts (NHDF)—3uM sphingosine-1-phosphate treated 12hr _vs_ untreated_GPL6480 |
Sphingosine 1-phosphate |
Dermal fibroblasts |
GSE56308 |
12 |
3 |
11.1 |
Macrophages treated 6hr with 10ug curdlan _vs_ untreated controls |
Curdlan |
Macrophage |
GSE32282 |
6 |
10ug/ml |
10.8 |
Hepatocellular carcinoma hepatocyte HepaRG cells + 6hr 100nM vinblastine _vs_ DMSO |
Vinblastine |
HepaRG |
GSE69851 |
6 |
100 |
10.4 |
Lung epithelium A549 cells 200ug/ml silica treated from 24hr _vs_ untreated |
Silicon dioxide |
A549 |
GSE30215 |
24 |
0.1 |
10.4 |
HL60 cells + amphotericin B, 4.4uM _vs_ DMSO vehicle |
Amphotericin B |
HL-60 |
GSE5258 |
6 |
4.4 |
10.3 |